Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Clinical Epidemiology Unit, Department of Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Ann Clin Transl Neurol. 2020 Nov;7(11):2094-2102. doi: 10.1002/acn3.51203. Epub 2020 Sep 21.
To conduct systematic review and meta-analysis for the efficacy of therapeutic plasma exchange (TPE) for neuromyelitis optica spectrum disorder (NMOSD) with an acute attack.
Systematic review was performed using EMBASE and OVID/Medline database. The eligible studies must be the studies of NMOSD patients treated with TPE during the acute phase. They must report treatment outcomes using either Expanded Disability Status Scale (EDSS) or visual acuity (VA) before and after the therapy. Pooled mean difference (MD) was then calculated by combining MDs of each study using the random-effects model.
Fifteen studies were identified; eleven with 241 NMOSD patients reported EDSS outcome and four studies with 103 NMOSD reported visual outcomes. The meta-analysis demonstrated a significantly decreased in EDSS after TPE treatment for NMOSD with an acute attack with the pooled MD of 0.83 (95% CI, 0.26-1.40; I 69%) comparing pretreatment to immediate posttreatment and 2.13 (95% CI, 1.55-2.70; I 31%) comparing pretreatment to posttreatment at 6 months to 1-year follow-up. Unfortunately, only one of the four studies evaluating visual outcomes reported standard deviation in association with mean LogMAR; therefore, the meta-analysis cannot be conducted. Nonetheless, all studies consistently demonstrated the benefit of TPE with improved VA and/or LogMAR after treatment.
This systematic review and meta-analysis showed the benefit of TPE during the NMOSD attack with a significantly improved disability status immediately after treatment and during follow-up.
对治疗性血浆置换(TPE)治疗视神经脊髓炎谱系疾病(NMOSD)急性发作的疗效进行系统评价和荟萃分析。
使用 EMBASE 和 OVID/Medline 数据库进行系统评价。合格的研究必须是在急性发作期间接受 TPE 治疗的 NMOSD 患者的研究。他们必须报告使用扩展残疾状况量表(EDSS)或治疗前后视力(VA)来评估治疗结果。然后使用随机效应模型合并每个研究的 MD 来计算合并均数差(MD)。
确定了 15 项研究;其中 11 项研究报告了 241 例 NMOSD 患者的 EDSS 结果,4 项研究报告了 103 例 NMOSD 患者的视力结果。荟萃分析表明,NMOSD 急性发作患者在接受 TPE 治疗后,EDSS 显著降低,立即治疗后 MD 为 0.83(95%CI,0.26-1.40;I 69%),与治疗前相比,6 个月至 1 年随访时 MD 为 2.13(95%CI,1.55-2.70;I 31%)。不幸的是,评估视力结果的四项研究中只有一项报告了与平均值相关的标准差 LogMAR;因此,无法进行荟萃分析。尽管如此,所有研究都一致表明,TPE 治疗后 VA 和/或 LogMAR 改善,NMOSD 患者受益。
本系统评价和荟萃分析显示,NMOSD 发作期间 TPE 治疗具有显著益处,治疗后即刻和随访期间残疾状况明显改善。